Liverpool’s Chargepoint manufactures containment valves used by chemical and pharmaceutical firms to manage the sterile transfer of controlled substances. An expanding customer base, as well as growing sales of spares and consumables, helped profits rise to £3.4m last year. In January, chief executive Chris Eccles, 38, led a buyout backed by the private equity firm LDC, for an undisclosed sum. The deal will help the group expand overseas, with a particular focus on North America.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanyChargePoint Technology
ActivityPrecision valve manufacturer
Annual profit growth89.26%
Latest profits £000s*3,367
Latest sales £000s*11,415

If applicable:

* supplied by company † annualised figure